Routine share withholding; mechanical by default.
Loading…
Traded Mar 9, 2026 · Filed Mar 11, 2026
The boss of Axon Enterprise sold $140K of Axon Enterprise shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$139,863
Shares × reported transaction price
13 days after results of Feb 24, 2026, 58 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $559.06 on Mar 9, 2026, 40% above its 52-week low and 36% below its high, after a 9% drop over the previous 30 trading days
52-week range $399.65 (Feb 5, 2026) to $870.97 (Aug 7, 2025), 34% of the way up, from 251 adjusted closes. 30 trading days earlier: $613.14 on Jan 23, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
A securities lawsuit naming the company as a defendant was filed on Feb 17, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.
NATHAN CUMMINGS FOUNDATION, INC. v. AXON ENTERPRISE, INC., docket 1:26-cv-00501, via CourtListener (court records). Nature of suit 850, company named as first defendant
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.6% | -0.9% | +1.5% |
| 30 days | -28.0% | +3.0% | -31.0% |
| 90 days | -10.4% | +8.9% | -19.3% |
| 180 days | +1.2% | +15.0% | -13.8% |
Past results only. Not a forecast.
Routine share withholding; mechanical by default.
Director sold ~$77K of Axon Enterprise
Scheduled in advanceA board member of Axon Enterprise sold $100K of Axon Enterprise shares. Nobody planned it ahead of time.